FELDMAN PAUL L enters AKTIS ONCOLOGY, INC. with 144.57K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/8/2026ACC: 0001193125-26-008060
Officer· Chief Scientific Officer
Since Jan 2026
144.57K
Baseline shares
100% direct
144.57K
Direct ownership
1 position
406.89K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned144.57K
Total
144.57K direct144.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 144.57K | Direct |
| Total | 144.57K | 144.57K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
131.25K
Shares owned
N/A
Exercise price
18.00
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
65.71K
Shares owned
N/A
Exercise price
1.91
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
90.68K
Shares owned
N/A
Exercise price
9.33
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
119.25K
Shares owned
N/A
Exercise price
3.66
Expiration
—
Exercise window
—
Total
Underlying
406.89K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 18.00 | — | — | 131.25K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.91 | — | — | 65.71K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.33 | — | — | 90.68K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.66 | — | — | 119.25K | N/A |
| Total | 406.89K | 0.00 | ||||